HR and breast cancer: Indeed, PIGNON identifies dysregulated functional annotations in the hormone receptor positive (HR+), human epidermal growth factor receptor 2 (HER2+) and triple negative (TN) breast cancer subtypes, providing insights into the molecular mechanisms of these conditions.